Jerel Davis's Form 4 filing
LENZ Therapeutics, Inc. (LENZ) · filed Jul 1, 2021
- Accession no.
- 0000899243-21-027017
- Filed
- Jul 1, 2021
- Trade date
- Jun 29, 2021
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions and 2 derivative transactions. Open-market purchases total $3.06M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Jerel DavisCIK 0001745958 | Director, 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 29, 2021 | Common Stock | CConversionAcquired | +12,343,727 | – | – | 14,708,398 | Indirect | |
| Jun 29, 2021 | Common Stock | CConversionAcquired | +1,527,719 | – | – | 1,527,719 | Indirect | |
| Jun 29, 2021 | Common Stock | PPurchaseAcquired | +180,000 | $17.00 | +$3,060,000 | 1,707,719 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 29, 2021 | Common Stock | CConversionDisposed | −12,343,727 | – | – | 0 | Indirect | |
| Jun 29, 2021 | Common Stock | CConversionDisposed | −1,527,719 | – | – | 0 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.